IVF רווח נקי למניה (EPS TTM) INVO Fertility Corp

Aggressive clinic network expansion and high costs at INVO Fertility Inc (IVF) are weighing on margins, as evidenced by the annual net income per share. The value of -123.31 defines the current magnitude of this metric. The company is implementing an affordable IVF alternative via in vivo embryo incubation. Simultaneously, incubator production lines remain stable while undergoing upgrades to leak control systems.

Investors are seeking fundamental stability by analyzing the real return on equity. This metric measures the annual net profit distributed per share, excluding the impact of leverage. For INVO Fertility Inc (IVF), the sales efficiency of the INVOcell system directly determines this result. Profit growth confirms the scaling of affordable IVF. Evaluate business dynamics through changes in the rolling net income per share.